文献速递心脑血管急症重症综合管理与镇静镇痛

心脏骤停后目标温度管理患者血小板计数时间变化与神经功能结局的关系

Time course of platelet counts in relation to the neurologic outcome in patients undergoing targeted temperature management after cardiac arrest.
PubMed 文献 · Resuscitation · 2019-05-24
一句话结论院外心脏骤停后接受目标温度管理患者中,第7天血小板计数低与6个月不良神经功能结局及死亡相关。

该研究回顾性分析了2009至2016年间连续261例院外心脏骤停后接受目标温度管理的患者,每日采集血样至第7天,主要结局为6个月时脑功能分级3-5级的不良神经功能结局。175例(67.0%)患者6个月时神经功能结局不良,良好结局组与不良结局组血小板计数随时间变化差异有统计学意义(p < 0.001),两组血小板在目标温度管理期间均下降,良好结局组在第一周末恢复至正常范围而不良结局组仍保持低值。调整协变量后,第7天血小板计数低与不良神经功能结局(aOR 0.975,95% CI 0.961-0.989)及6个月死亡(aOR 0.986,95% CI 0.975-0.997)相关。

要点

  • 261例院外心脏骤停后接受目标温度管理患者中,175例(67.0%)6个月时神经功能结局不良(脑功能分级3-5级)。
  • 良好结局组与不良结局组血小板计数随时间变化差异有统计学意义(p < 0.001)。
  • 两组血小板在目标温度管理期间均下降,良好结局组第一周末恢复至正常范围,不良结局组仍保持低值。
  • 调整协变量后,第7天血小板计数低与不良神经功能结局相关(aOR 0.975,95% CI 0.961-0.989)。
  • 调整协变量后,第7天血小板计数低与6个月死亡相关(aOR 0.986,95% CI 0.975-0.997)。

适用人群与场景

  • 2009至2016年间连续收治的院外心脏骤停后接受目标温度管理的患者。

诊断标准与关键阈值

  • 不良神经功能结局定义为心脏骤停后6个月脑功能分级(Cerebral Performance Category)3-5级。

研究设计与关键结果

  • 研究类型为连续病例回顾,共纳入261例院外心脏骤停后接受目标温度管理的患者。
  • 主要终点:175例(67.0%)患者6个月时神经功能结局不良(脑功能分级3-5级)。
  • 良好结局组与不良结局组血小板计数随时间变化差异有统计学意义(p < 0.001)。
  • 两组血小板在目标温度管理期间均下降;良好结局组第一周末恢复至正常范围,不良结局组仍保持低值。
  • 调整协变量后,第7天血小板计数低与不良神经功能结局相关(aOR 0.975,95% CI 0.961-0.989)。
  • 调整协变量后,第7天血小板计数低与6个月死亡相关(aOR 0.986,95% CI 0.975-0.997)。

证据类型、等级与局限

  • 证据类型:回顾性连续病例分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为院外心脏骤停后目标温度管理患者血小板计数呈双相模式,良好与不良神经功能结局组间差异显著。
  • 作者认为心脏骤停后第7天血小板计数低与6个月不良神经功能结局及死亡相关。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Thrombocytopenia is common and associated with mortality in critically ill patients. However, the time course of platelet counts and its association with the neurologic outcome after out-of-hospital cardiac arrest (OHCA) are not well known. The purpose of this study is to describe the time course of platelet counts in relation to the neurologic outcome in patients undergoing targeted temperature management (TTM) after CA.

METHODS: Review of consecutive patients receiving TTM after out-of-hospital CA between 2009 and 2016. The blood sample was collected daily until 7 days. The primary outcome was poor neurologic outcome at 6 months after CA defined as Cerebral Performance Category of 3-5 and secondary outcome was mortality at 6 months.

RESULTS: A total of 261 consecutive patients treated with TTM after OHCA between 2009 and 2016. One hundred seventy-five patients (67.0%) had poor neurologic outcomes 6 months after CA. The changes in the platelet counts over time between the good and poor outcome groups were statistically significant (p < 0.001). The platelet counts declined during TTM in both groups. The platelet counts recovered to the normal range at the end of the first week in the good neurologic outcome group. However, the platelet counts remained low in the poor outcome group. Low platelet counts on the 7th day were associated with poor neurologic outcomes (aOR 0.975, 95% CI, 0.961-0.989) and mortality at 6 months (aOR 0.986, 95% CI, 0.975-0.997) after adjusting for covariates.

CONCLUSION: The changes in platelet counts in OHCA patients have a biphasic pattern that is significantly different in patients with good neurologic outcomes and those with poor neurologic outcomes at 6 months. A low platelet count 7 days after CA was associated with a poor neurologic outcome and mortality at 6 months.

来源:Resuscitation,查看原文。版权归原作者所有。

参考来源

  1. Kim HJ, Park KN, Kim SH, et al. Time course of platelet counts in relation to the neurologic outcome in patients undergoing targeted temperature management after cardiac arrest. Resuscitation. 2019. PMID: 31132395. doi:10.1016/j.resuscitation.2019.05.019

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。